- To establish whether treatment with corticosteroid-cyclophosphamide induced remission of nephrotic syndrome in a significantly greater number of patients than treatment with tacrolimus-rituximab, although side-effects were more frequent in the former group.
- To determine clinical significance of study results.
Friday, June 18, 2021 - 12:00pm to 1:00pm
5700 S. Maryland Ave
Chicago, IL 60637
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Sri Mahathi Kalipatnapu, MD